CCK‐JMV‐180 acts as an antagonist of the CCK<sub>A</sub> receptor in the human IMR‐32 neuroblastoma cell line
Paul Schaeffer(Universidad La Salle), Jean Marc Herbert(Sanofi (France)), V. Prabonnaud(Sanofi (France)), D. Gully(Sanofi (France)), Matthias Roux(Sanofi (France))
Cited by 6
Related Papers
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|943
PGC-1α Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERRα: a Mechanism for Transcriptional Control of Muscle Glucose Metabolism
|Molecular and Cellular Biology|2005|355
The Lectin-like Domain of Thrombomodulin Confers Protection from Neutrophil-mediated Tissue Damage by Suppressing Adhesion Molecule Expression via Nuclear Factor κB and Mitogen-activated Protein Kinase Pathways
|The Journal of Experimental Medicine|2002|349
Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart
|Genes & Development|2008|325
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy
|Journal of Clinical Investigation|2005|260